Beyond Algorithms: AI Solutions for Canada’s Healthcare Challenges
Webcast on Cisco Webex with Ryan MacDonald and Dr. Nicole Mittmann
Sponsored by:
C.D. Howe Institute events are exclusive to members and their guests, with webcasts available to the public.
Please contact Adi Malev, Event Planner to complimentarily register: amalev@cdhowe.org
Ryan MacDonald, Director, Health AI Implementation, Vector Institute
Ryan MacDonald is the Director of Health AI Implementation at the Vector Institute, one of Canada’s 3 national institutes dedicated to research and application in the field of artificial intelligence (AI). Ryan and his team work closely with healthcare institutions and providers to enable health AI deployment in order to improve patient outcomes and care delivery.
Before joining Vector, Ryan worked as a Senior Manager in KPMG’s Healthcare practice in management consulting focused on transformation in the health and social care space. Ryan has led teams supporting system wide digital and operational transformation in Canada, the United States and the Caribbean.
Ryan has a Master of Public Policy from the Munk School of Global Affairs and Public Policy at the University of Toronto and has gone on to do certifications at Cornell University and Massachusetts Institute of Technology (MIT) in data analytics and artificial intelligence.
Dr. Nicole Mittmann, Chief Scientist and Vice President, Scientific Evidence, Methodologies, and Resources, Canada’s Drug Agency (CADTH)
In her Chief Scientist role, Dr. Mittmann is responsible for ensuring that CDA (a.ka. CADTH) actively learns, ensures rigour and quality, mobilizes evidence, and links science to strategy. In her Scientific Evidence, Methodologies and Resources role, Nicole leads CDA’s shared science groups, including the Science and Methods, Health Economics, Research Information Services, Publishing, Early Scientific Advice and Real-World Evidence teams.
In her academic capacity, Dr. Mittmann holds an MSc and PhD in pharmacology from the University of Toronto. She holds a faculty position as an assistant professor at the University of Toronto in the Department of Pharmacology & Toxicology; and is cross-appointed to the Institute for Health Policy, Management and Evaluation. She is also an associate scientist at Sunnybrook Health Sciences Centre in Toronto, Canada. Dr. Mittmann has conducted and collaborated on notable research in the areas of economic evaluations, outcomes research, and drug/patient safety. Research methodologies include the examination of large databases, economic methodologies, and decision analysis.
She likes to link, leverage and liberate data and evidence.
to ET